Boston Trust Walden’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $30M | Sell |
82,829
-1,723
| -2% | -$590K | 0.23% | 149 |
|
|
2026
Q1 | $29.7M | Buy |
84,552
+12,647
| +18% | +$4.51M | 0.24% | 145 |
|
|
2025
Q4 | $23.5M | Buy |
71,905
+57,235
| +390% | +$18.2M | 0.18% | 171 |
|
|
2025
Q3 | $4.14M | Sell |
14,670
-19,260
| -57% | -$5.59M | 0.03% | 231 |
|
|
2025
Q2 | $9.47M | Sell |
33,930
-10,590
| -24% | -$3M | 0.07% | 207 |
|
|
2025
Q1 | $13.9M | Buy |
44,520
+5,983
| +16% | +$1.77M | 0.1% | 191 |
|
|
2024
Q4 | $10M | Sell |
38,537
-243
| -0.6% | -$72.1K | 0.07% | 206 |
|
|
2024
Q3 | $12.5M | Sell |
38,780
-3,930
| -9% | -$1.29M | 0.09% | 192 |
|
|
2024
Q2 | $13.3M | Sell |
42,710
-890
| -2% | -$261K | 0.1% | 184 |
|
|
2024
Q1 | $12.4M | Sell |
43,600
-60
| -0.1% | -$17.6K | 0.09% | 187 |
|
|
2023
Q4 | $12.6M | Sell |
43,660
-290
| -0.7% | -$79K | 0.09% | 182 |
|
|
2023
Q3 | $11.8M | Buy |
43,950
+4,650
| +12% | +$1.16M | 0.1% | 185 |
|
|
2023
Q2 | $8.73M | Sell |
39,300
-1,555
| -4% | -$361K | 0.07% | 204 |
|
|
2023
Q1 | $9.88M | Sell |
40,855
-6,850
| -14% | -$1.68M | 0.09% | 198 |
|
|
2022
Q4 | $12.5M | Buy |
47,705
+11,965
| +33% | +$3.21M | 0.11% | 191 |
|
|
2022
Q3 | $8.06M | Buy |
35,740
+1,205
| +3% | +$292K | 0.08% | 205 |
|
|
2022
Q2 | $8.4M | Sell |
34,535
-3,842
| -10% | -$941K | 0.08% | 209 |
|
|
2022
Q1 | $9.28M | Sell |
38,377
-117,946
| -75% | -$27.1M | 0.08% | 210 |
|
|
2021
Q4 | $35.2M | Sell |
156,323
-17,531
| -10% | -$3.7M | 0.28% | 124 |
|
|
2021
Q3 | $37M | Sell |
173,854
-20,877
| -11% | -$4.81M | 0.33% | 109 |
|
|
2021
Q2 | $47.5M | Buy |
194,731
+8,530
| +5% | +$2.1M | 0.42% | 81 |
|
|
2021
Q1 | $46.3M | Buy |
186,201
+26,825
| +17% | +$6.4M | 0.45% | 71 |
|
|
2020
Q4 | $36.6M | Buy |
159,376
+15,746
| +11% | +$3.63M | 0.39% | 85 |
|
|
2020
Q3 | $36.5M | Buy |
143,630
+129,956
| +950% | +$32.2M | 0.45% | 66 |
|
|
2020
Q2 | $3.23M | Sell |
13,674
-50
| -0.4% | -$11.4K | 0.04% | 248 |
|
|
2020
Q1 | $2.78M | Sell |
13,724
-122
| -0.9% | -$26.6K | 0.04% | 248 |
|
|
2019
Q4 | $3.34M | Sell |
13,846
-123
| -0.9% | -$27.1K | 0.04% | 254 |
|
|
2019
Q3 | $2.7M | Sell |
13,969
-366
| -3% | -$70.3K | 0.03% | 255 |
|
|
2019
Q2 | $2.64M | Buy |
14,335
+2,436
| +20% | +$436K | 0.03% | 259 |
|
|
2019
Q1 | $2.26M | Sell |
11,899
-3,949
| -25% | -$754K | 0.03% | 268 |
|
|
2018
Q4 | $3.08M | Sell |
15,848
-2,980
| -16% | -$581K | 0.05% | 249 |
|
|
2018
Q3 | $3.9M | Buy |
18,828
+1,000
| +6% | +$197K | 0.05% | 237 |
|
|
2018
Q2 | $3.29M | Sell |
17,828
-45
| -0.3% | -$7.96K | 0.05% | 245 |
|
|
2018
Q1 | $3.05M | Buy |
17,873
+2,150
| +14% | +$395K | 0.05% | 251 |
|
|
2017
Q4 | $2.73M | Hold |
15,723
| – | – | 0.04% | 258 |
|
|
2017
Q3 | $2.93M | Buy |
15,723
+310
| +2% | +$54.9K | 0.05% | 256 |
|
|
2017
Q2 | $2.65M | Buy |
15,413
+675
| +5% | +$110K | 0.04% | 257 |
|
|
2017
Q1 | $2.42M | Buy |
14,738
+2,420
| +20% | +$402K | 0.04% | 254 |
|
|
2016
Q4 | $1.8M | Sell |
12,318
-1,525
| -11% | -$230K | 0.03% | 271 |
|
|
2016
Q3 | $2.31M | Buy |
13,843
+25
| +0.2% | +$4.23K | 0.04% | 257 |
|
|
2016
Q2 | $2.1M | Buy |
13,818
+2,150
| +18% | +$334K | 0.04% | 265 |
|
|
2016
Q1 | $1.75M | Sell |
11,668
-110
| -0.9% | -$16.3K | 0.03% | 272 |
|
|
2015
Q4 | $1.91M | Sell |
11,778
-930
| -7% | -$146K | 0.04% | 261 |
|
|
2015
Q3 | $1.76M | Sell |
12,708
-1,490
| -10% | -$235K | 0.03% | 265 |
|
|
2015
Q2 | $2.18M | Buy |
14,198
+133
| +0.9% | +$21.3K | 0.03% | 251 |
|
|
2015
Q1 | $2.25M | Sell |
14,065
-550
| -4% | -$86.6K | 0.03% | 244 |
|
|
2014
Q4 | $2.33M | Buy |
14,615
+600
| +4% | +$93.5K | 0.03% | 239 |
|
|
2014
Q3 | $1.97M | Buy |
14,015
+335
| +2% | +$43.7K | 0.03% | 240 |
|
|
2014
Q2 | $1.62M | Buy |
13,680
+8,375
| +158% | +$969K | 0.02% | 246 |
|
|
2014
Q1 | $654K | Sell |
5,305
-20,000
| -79% | -$2.43M | 0.01% | 275 |
|
|
2013
Q4 | $2.89M | Buy |
25,305
+2,605
| +11% | +$296K | 0.04% | 213 |
|
|
2013
Q3 | $2.54M | Buy |
22,700
+19,800
| +683% | +$2.15M | 0.04% | 212 |
|
|
2013
Q2 | $286K | Buy |
+2,900
| New | +$301K | ﹤0.01% | 298 |
|
Other funds holding AMGN
FFM
SP
BCWM
Boston Trust Walden's AMGN Position: Q2 2026 in Review
Boston Trust Walden reduced its Amgen (AMGN) stake by 2% in Q2 2026, selling an estimated $590K and leaving 82,829 shares worth $30M. The position accounts for 0.23% of the portfolio, ranked #149.
Boston Trust Walden first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $47.5M in Q2 2021. 1,172 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Boston Trust Walden held 82,829 shares of Amgen worth $30M as of Q2 2026.
- Boston Trust Walden sold 1,723 Amgen shares in Q2 2026, an estimated $590K.
- Amgen made up 0.23% of Boston Trust Walden's portfolio in Q2 2026, its #149 holding.
- Boston Trust Walden first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
- Boston Trust Walden's Amgen position peaked at $47.5M in Q2 2021.
- 1,172 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.